Operating Income - CJ Bioscience Inc (KOSDAQ:311690) - Alpha Spread
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 12 000 KRW 1.1% Market Closed
Market Cap: 109.4B KRW
Have any thoughts about
CJ Bioscience Inc?
Write Note

CJ Bioscience Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CJ Bioscience Inc
Operating Income Peer Comparison

Comparables:
U
032620
D
315640
e
099750
L
328130
J
322510

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
CJ Bioscience Inc
KOSDAQ:311690
Operating Income
-â‚©32.1B
CAGR 3-Years
-56%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
U
UBCare Co Ltd
KOSDAQ:032620
Operating Income
â‚©1.8B
CAGR 3-Years
-51%
CAGR 5-Years
-34%
CAGR 10-Years
-3%
D
DeepNoid Inc
KOSDAQ:315640
Operating Income
-â‚©6.7B
CAGR 3-Years
-10%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Operating Income
-â‚©4.1B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Operating Income
-â‚©42.2B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Operating Income
-â‚©7.1B
CAGR 3-Years
2%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is CJ Bioscience Inc's Operating Income?
Operating Income
-32.1B KRW

Based on the financial report for Dec 31, 2023, CJ Bioscience Inc's Operating Income amounts to -32.1B KRW.

What is CJ Bioscience Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-57%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for CJ Bioscience Inc have been -56% over the past three years , -57% over the past five years .

Back to Top